The Devyser blog

Devyser has inaugurated its CLIA-certified laboratory in Atlanta, Georgia. The laboratory will...

Devyser is thrilled to announce the launch of two new products, Devyser LynchFAP and Devyser BRCA...

Fetal derived cell-free DNA (cfDNA) is a key analyte for determining fetal RHD status in plasma...

Devyser is today announcing that its product for non-invasive fetal RHD testing has been granted...

“The first quarter of the year saw continued strong growth, record gross margin and the launching...

Devyser is today announcing that the company’s clinical testing laboratory in Roswell in Atlanta,...

Devyser has been awarded the Swecare Export Award 2023. The prize is awarded to companies that...

Collaboration and distribution agreement with Thermo Fisher Scientific Thermo Fisher Scientific...

As a lab manager, you know the importance of streamlining workflows to maximize productivity and...

Devyser´s annual report 2022 has today been published on the company´s website. The report is...

Devyser announced in Aug 2022 that we received our first IVDR certificate from the notified body...

With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...